Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Psyence Biomedical Ltd. (PBM) had Operating Cash Flow per Share of $-19.34 for the most recently reported fiscal year, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$1.01M |
|
-- |
|
-- |
|
$3.66M |
|
$-3.66M |
|
$4.68M |
|
$1.01M |
|
$1.01M |
|
$1.01M |
|
$1.01M |
|
$1.01M |
|
$1.01M |
|
$-3.66M |
|
$-3.66M |
|
0.19M |
|
0.19M |
|
$5.24 |
|
$5.24 |
|
| Balance Sheet Financials | |
$6.56M |
|
$0.01M |
|
$0.76M |
|
$7.32M |
|
$0.59M |
|
-- |
|
-- |
|
$0.59M |
|
$6.72M |
|
$6.72M |
|
$6.72M |
|
0.57M |
|
| Cash Flow Statement Financials | |
$-3.73M |
|
$-0.02M |
|
$9.15M |
|
$0.73M |
|
$6.14M |
|
$5.40M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.04 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.74M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
15.05% |
|
15.05% |
|
13.83% |
|
15.05% |
|
$11.83 |
|
$-19.40 |
|
|
Operating Cash Flow per Share |
$-19.34 |